Insider Buying: PolyNovo (ASX:PNV) Insider Purchases A$27,840.00 in Stock

PolyNovo Limited (ASX:PNV) insider Leon Hoare acquired 20,000 shares of the business’s stock in a transaction that occurred on Thursday, September 11th. The stock was bought at an average cost of A$1.39 per share, for a total transaction of A$27,840.00.

PolyNovo Price Performance

The company has a quick ratio of 1.58, a current ratio of 3.41 and a debt-to-equity ratio of 21.32. The company has a market capitalization of $1.30 billion, a P/E ratio of 247.31, a P/E/G ratio of 2.63 and a beta of 1.67.

About PolyNovo

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound.